Global AI-based Clinical Trials Solution Provider Market Analysis, Size, Growth, Share, Trend, Outlook & Forecast to 2028
AI-based Clinical Trials Solution Provider Market Growth & Trends The global AI-based clinical trials solution provider market size is expected to reach USD 5.2 billion by 2028 and is expected to expand at a CAGR of 21.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising adoption of AI-based platforms and technologies by pharmaceutical companies and academia, along with increasing adoption of artificial intelligence (AI) are among the factors driving the market growth. In addition, increasing public and private sector offerings for boosting the research and development in various therapeutic areas, coupled with diverse applications provided by AI in the field of clinical trials is further supporting the growth. Based on phase, the phase-II segment dominated the market with a share of 48.5% in 2020. This high share is attributable to a higher number of active interventional studies in the second phase. Furthermore, the second phase is crucial for analyzing the immediate outcome of the overall desired outcome from the completion of clinical trials. In addition, since improvements in the further phases of the trial and determination of measures with regards to AI-based tools can be effectively carried out in this phase, the segment comprises of higher revenue share. Download Exclusive Sample Report (118 Pages PDF with All Related Graphs & Charts) For Free @ https://www.grandviewresearch.com/industry-analysis/artificial-intelligencebased-clinical-trials-solution-provider-market
North America dominated the market and accounted for the largest revenue share of 43.6% in 2020 owing to various factors including a rising number of start-ups and AI in drug